We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

Back to rankings

46 hedge funds and large institutions have $22.3M invested in EnteroMedics Inc. in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more call options, than puts

Call options by funds: $225K | Put options by funds: $151K

13% more capital invested

Capital invested by funds: $19.8M → $22.3M (+$2.53M)

6% less funds holding

Funds holding: 49 → 46 (-3)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
9
Closed
10
Calls
$225K
Puts
$151K
Net Calls
+$74K
Net Calls Change
-$401K

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$494K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$189K
3
IHM
Iguana Healthcare Management
New York
+$130K
4
OAM
Oxford Asset Management
United Kingdom
+$37.8K
5
PP
Paloma Partners
Connecticut
+$36.5K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$798K
2
Wells Fargo
Wells Fargo
California
-$161K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
-$143K
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$136K
5
Goldman Sachs
Goldman Sachs
New York
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$5.82M – – –
IHM
2
Iguana Healthcare Management
New York
$3.47M +$130K +96 +4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.37M +$189K +140 +10%
Wells Fargo
4
Wells Fargo
California
$2.19M -$161K -119 -8%
FAM
5
Fred Alger Management
New York
$1.71M +$494K +366 +47%
RSCM
6
Rock Springs Capital Management
Maryland
$1.6M – – –
MAM
7
MPM Asset Management
Massachusetts
$1.58M – – –
B
8
Bailard
California
$451K – – –
VAM
9
Visium Asset Management
New York
$444K – – –
JGC
10
J. Goldman & Co
New York
$391K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$369K – – –
1CM
12
1492 Capital Management
Wisconsin
$254K -$14.9K -11 -6%
BFA
13
BlackRock Fund Advisors
California
$228K +$14.9K +11 +8%
BCCM
14
Blue Clay Capital Management
Minnesota
$203K +$184K +136 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$155K +$1.35K +1 +1%
HCM
16
Highlander Capital Management
New Jersey
$142K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$125K -$143K -106 -50%
TD Asset Management
18
TD Asset Management
Ontario, Canada
$119K – – –
Northern Trust
19
Northern Trust
Illinois
$115K – – –
DWT
20
Dorsey & Whitney Trust
South Dakota
$84K – – –
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$73K -$68.9K -51 -51%
OAM
22
Oxford Asset Management
United Kingdom
$41K +$37.8K +28 New
PP
23
Paloma Partners
Connecticut
$40K +$36.5K +27 New
MAA
24
Managed Account Advisors
New Jersey
$39K +$4.05K +3 +13%
RCM
25
Rotella Capital Management
Washington
$35K -$2.7K -2 -8%
1
2 3

ETRM Hedge Fund Activity: Q4 2014 in Review

46 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q4 2014, worth a combined $22.3M — up 13% from $19.8M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ETRM and 8 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Fred Alger Management, adding an estimated $494K. The largest seller was Royce & Associates, exiting entirely with an estimated $798K sold.

  • 46 institutional investors held EnteroMedics Inc. (ETRM) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $22.3M of EnteroMedics Inc. stock for Q4 2014, up 13% quarter-over-quarter.
  • 8 funds opened new EnteroMedics Inc. positions in Q4 2014 and 10 closed out, a net change of -2 holders.
  • The largest EnteroMedics Inc. buyer in Q4 2014 was Fred Alger Management, an estimated $494K added.
  • The largest EnteroMedics Inc. seller in Q4 2014 was Royce & Associates, an estimated $798K sold.

Based on aggregated 13F filings for Q4 2014.